United States · FDA National Drug Code directory
Exforge HCT
A source-listed medicine record.
Factual source checks only. This page is not a clinically reviewed monograph. Historical or discontinued records may be included; listing does not confirm approval, current availability or pharmacy stock.
Medicine identity
- Source reference
- 0078-0561_e10fea42-c6e7-4584-9a0a-0709c5323cd8
- Product NDC
- 0078-0561
- Form
- TABLET, FILM COATED
- Composition / generic term
- amlodipine valsartan and hydrochlorothiazide
- Labeler
- Novartis Pharmaceuticals Corporation
- Marketing category
- NDA
- Marketing start / end (source format)
- 20090404
- Source listing expiry
- 20261231
Source-listed ingredients
- AMLODIPINE BESYLATE — 10 mg/1
- VALSARTAN — 160 mg/1
- HYDROCHLOROTHIAZIDE — 12.5 mg/1
These values do not establish equivalence or a dose recommendation.
Packages
- 30 TABLET, FILM COATED in 1 BOTTLE (0078-0561-15) · 0078-0561-15
Source and coverage
Open FDA National Drug Code directory →
Snapshot retrieved: 2026-09-17. This is the acquisition date, not a medical review date.
Clinical information, images and comparisons appear only when separately reviewed for this record. Coverage may be incomplete. Ask a pharmacist or clinician about your treatment.
Browse United States records →